« Previous
Next »
Titles
- HHS's Office of Refugee Resettlement improved coordination and outreach to promote the safety and well-being of unaccompanied alien children1
- HRSA helped health centers with elevated risks and can continue to take additional steps1
- Health and Human Services funding for abstinence education, education for teen pregnancy, and HIV/STD prevention, and other programs that address adolescent sexual activity1
- Health care: telehealth and remote patient monitoring use in Medicare and selected federal programs : report to Congressional committees1
- Health coverage under the Affordable Care Act: enrollment trends and state estimates1
- Health document submission requirements for tobacco products: (revised)1
- Health information technology: HHS should assess the effectiveness of its efforts to enhance patient access to and use of electronic health information : report to Congressional requesters1
- Health insurance coverage and access to care among Latinos: recent trends and key challenges1
- Health insurance exchanges: HHS should enhance its management of open enrollment performance : report to Congressional requesters1
- Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment1
- Hospital capabilities to enable patient electronic access to health information: 20191
- Hospital value-based purchasing: CMS should take steps to ensure lower quality hospitals do not qualify for bonuses : report to Congressional committees1
- Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia: developing drugs for treatment1
- Hospitals reported improved preparedness for emerging infectious diseases after the Ebola outbreak1
- Hospitals' use of electronic health records data: 2015-20171
- How to prepare a pre-request for designation (pre-RFD)1
- Human gene therapy for hemophilia1
- Human gene therapy for rare diseases1
- Human gene therapy for retinal disorders1
- Human immunodeficiency virus-1 infection: developing systemic drug products for pre-exposure prophylaxis1